AbCellera Biologics Inc vs Uranium Energy Corp — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while Uranium Energy Corp trades at $11.58 (market cap $5.67B). The key difference: Uranium Energy Corp is the larger of the two by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Uranium Energy Corp nearer its low. Which is the better fit depends on your goals.
| ABCL | UEC | |
|---|---|---|
Market Cap | $2.99B | $5.67B |
Sector | Health | Energy |
52-Week High | $9.76 | $20.14 |
52-Week Low | $2.78 | $9.04 |
Enterprise Value | $2.58B | $5.18B |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →